Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

Idanna Innocenti, Francesca Morelli, Francesco Autore, Alfonso Piciocchi, Annamaria Frustaci, Francesca R. Mauro, Luana Schiattone, Livio Trentin, Giovanni Del Poeta, Gianluigi Reda, Gian M. Rigolin, Adalberto Ibatici, Stefania Ciolli, Marta Coscia, Paolo Sportoletti, Roberta Murru, Luciano Levato, Massimo Gentile, Giovanni D'Arena, Dimitar G. EfremovAlessandra Tedeschi, Lydia Scarfò, Antonio Cuneo, Robin Foà, Luca Laurenti

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e8-e11
JournalBritish Journal of Haematology
Volume187
Issue number1
DOIs
Publication statusPublished - Oct 1 2019

Keywords

  • B-Cell receptor
  • chronic lymphocytic leukaemia
  • ibrutinib
  • idelalisib
  • venetoclax

ASJC Scopus subject areas

  • Hematology

Cite this

Innocenti, I., Morelli, F., Autore, F., Piciocchi, A., Frustaci, A., Mauro, F. R., Schiattone, L., Trentin, L., Del Poeta, G., Reda, G., Rigolin, G. M., Ibatici, A., Ciolli, S., Coscia, M., Sportoletti, P., Murru, R., Levato, L., Gentile, M., D'Arena, G., ... Laurenti, L. (2019). Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience. British Journal of Haematology, 187(1), e8-e11. https://doi.org/10.1111/bjh.16123